Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

被引:0
|
作者
K A van Nifterik
J van den Berg
W F van der Meide
N Ameziane
L E Wedekind
R D M Steenbergen
S Leenstra
M V M Lafleur
B J Slotman
L J A Stalpers
P Sminia
机构
[1] VU University Medical Center,Department of Radiation Oncology
[2] VU University Medical Center,Department of Pathology
[3] VU University Medical Center,Department of Clinical Genetics
[4] St Elisabeth Ziekenhuis,Department of Neurosurgery
[5] Academic Medical Center,Department of Radiotherapy
来源
British Journal of Cancer | 2010年 / 103卷
关键词
MGMT; temozolomide; glioma; prediction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:29 / 35
页数:6
相关论文
共 50 条
  • [21] A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
    Calegari, M. A.
    Inno, A.
    Monterisi, S.
    Orlandi, A.
    Santini, D.
    Basso, M.
    Cassano, A.
    Martini, M.
    Cenci, T.
    de Pascalis, I.
    Camarda, F.
    Barbaro, B.
    Larocca, L. M.
    Gori, S.
    Tonini, G.
    Barone, C.
    BRITISH JOURNAL OF CANCER, 2017, 116 (10) : 1279 - 1286
  • [22] MGMT promoter methylation status in clival chordoma
    Marucci, Gianluca
    Morandi, Luca
    Mazzatenta, Diego
    Frank, Giorgio
    Pasquini, Ernesto
    Foschini, Maria Pia
    JOURNAL OF NEURO-ONCOLOGY, 2014, 118 (02) : 271 - 276
  • [23] Predictive markers for MGMT promoter methylation in glioblastomas
    Kanazawa, Tokunori
    Minami, Yasuhiro
    Jinzaki, Masahiro
    Toda, Masahiro
    Yoshida, Kazunari
    Sasaki, Hikaru
    NEUROSURGICAL REVIEW, 2019, 42 (04) : 867 - 876
  • [24] The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
    Jovanovic, Nikola
    Mitrovic, Tatjana
    Cvetkovic, Vladimir J.
    Tosic, Svetlana
    Vitorovic, Jelena
    Stamenkovic, Slavisa
    Nikolov, Vesna
    Kostic, Aleksandar
    Vidovic, Natasa
    Krstic, Miljan
    Jevtovic-Stoimenov, Tatjana
    Pavlovic, Dusica
    MEDICINA-LITHUANIA, 2019, 55 (02):
  • [25] Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastoma
    Han, Xinyu
    Abdallah, Mohammed O. E.
    Breuer, Peter
    Stahl, Fabian
    Bakhit, Yousuf
    Potthoff, Anna-Laura
    Pregler, Barbara E. F.
    Schneider, Matthias
    Waha, Andreas
    Wuellner, Ullrich
    Evert, Bernd O.
    NEOPLASIA, 2023, 44
  • [26] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Consolación Melguizo
    Jose Prados
    Beatriz González
    Raul Ortiz
    Angel Concha
    Pablo Juan Alvarez
    Roberto Madeddu
    Gloria Perazzoli
    Jaime Antonio Oliver
    Rodrigo López
    Fernando Rodríguez-Serrano
    Antonia Aránega
    Journal of Translational Medicine, 10
  • [27] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Melguizo, Consolacion
    Prados, Jose
    Gonzalez, Beatriz
    Ortiz, Raul
    Concha, Angel
    Juan Alvarez, Pablo
    Madeddu, Roberto
    Perazzoli, Gloria
    Antonio Oliver, Jaime
    Lopez, Rodrigo
    Rodriguez-Serrano, Fernando
    Aranega, Antonia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [28] MGMT promoter methylation status in clival chordoma
    Gianluca Marucci
    Luca Morandi
    Diego Mazzatenta
    Giorgio Frank
    Ernesto Pasquini
    Maria Pia Foschini
    Journal of Neuro-Oncology, 2014, 118 : 271 - 276
  • [29] MGMT promoter methylation in malignant gliomas
    Markus J. Riemenschneider
    Monika E. Hegi
    Guido Reifenberger
    Targeted Oncology, 2010, 5 : 161 - 165
  • [30] MGMT Gene Promoter Methylation Analysis by Pyrosequencing of Brain Tumour
    Kim, Young Zoon
    Song, Young Jin
    Kim, Ki Uk
    Kim, Dae Cheol
    KOREAN JOURNAL OF PATHOLOGY, 2011, 45 (05) : 455 - 462